Case Report
Copyright ©2014 Baishideng Publishing Group Inc.
World J Hepatol. Jul 27, 2014; 6(7): 532-537
Published online Jul 27, 2014. doi: 10.4254/wjh.v6.i7.532
Table 2 Proposed mechanism for reduction in concentrations of procoagulant and anticoagulant proteins in patients with portal vein thrombosis
Hereditary or acquired thrombophilia
Reduced hepatic blood flow
Reduced synthesis
Portal hypertension
Portosystemic shunting
Clearance or consumption
Portal pyaemia or other local inflammatory disease
Portal vein thrombosis
Reduced levels of procoagulant and anticoagulant proteins